CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 58 filers reported holding CIDARA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $66,000 | +22.2% | 24,872 | -8.1% | 0.00% | – |
Q4 2020 | $54,000 | +12.5% | 27,062 | +59.4% | 0.00% | – |
Q3 2020 | $48,000 | -15.8% | 16,978 | +10.4% | 0.00% | – |
Q2 2020 | $57,000 | +256.2% | 15,376 | +254.4% | 0.00% | – |
Q4 2019 | $16,000 | +14.3% | 4,339 | -50.4% | 0.00% | – |
Q2 2019 | $14,000 | -39.1% | 8,755 | -0.8% | 0.00% | – |
Q1 2019 | $23,000 | -85.1% | 8,827 | -74.8% | 0.00% | – |
Q3 2018 | $154,000 | +250.0% | 35,060 | +214.9% | 0.00% | – |
Q1 2018 | $44,000 | -91.9% | 11,133 | -86.1% | 0.00% | – |
Q4 2017 | $543,000 | -62.5% | 79,981 | -55.3% | 0.00% | -100.0% |
Q3 2017 | $1,449,000 | +436.7% | 179,012 | +396.3% | 0.00% | – |
Q2 2017 | $270,000 | +1025.0% | 36,068 | +1040.3% | 0.00% | – |
Q1 2017 | $24,000 | -70.7% | 3,163 | -60.9% | 0.00% | – |
Q4 2016 | $82,000 | +310.0% | 8,092 | +359.0% | 0.00% | – |
Q3 2016 | $20,000 | +25.0% | 1,763 | +7.3% | 0.00% | – |
Q2 2016 | $16,000 | +77.8% | 1,643 | +127.9% | 0.00% | – |
Q1 2016 | $9,000 | -55.0% | 721 | -39.5% | 0.00% | – |
Q4 2015 | $20,000 | +25.0% | 1,191 | -10.2% | 0.00% | – |
Q3 2015 | $16,000 | 0.0% | 1,326 | +14.6% | 0.00% | – |
Q2 2015 | $16,000 | – | 1,157 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |